Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
T cell dysfunction
Description:
Impaired or altered T lymphocyte activity that compromises immune responses and can arise in diseases or their treatment.
Related topics:
Cancer Immunotherapy and Biomarkers (15%),
T-cell and B-cell Immunology (12%)
OpenAlex ID:
keywords/t-cell-dysfunction
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018
·
Peng Jiang
, Shengqing Gu
, et al.
·
Nature Medicine
·
6,143
T cell exhaustion
2011
·
E John Wherry
·
Nature Immunology
·
4,654
Restoring function in exhausted CD8 T cells during chronic viral infection
2005
·
Daniel L. Barber
, E. John Wherry
, et al.
·
Nature
·
4,369
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
2020
·
Meijuan Zheng
, Yong Gao
, et al.
·
Cellular and Molecular Immunology
·
1,929
PDF
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
2006
·
Lydie Trautmann
, Loury Janbazian
, et al.
·
Nature Medicine
·
1,722
CD8+ T cell states in human cancer: insights from single-cell analysis
2020
·
Anne M. van der Leun
, Daniela S. Thommen
, et al.
·
Nature reviews. Cancer
·
1,609
T Cell Dysfunction in Cancer
2018
·
Daniela S. Thommen
, Ton N. Schumacher
·
Cancer Cell
·
1,440
PDF
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients
2010
·
Julien Fourcade
, Zhaojun Sun
, et al.
·
The Journal of Experimental Medicine
·
1,415
PDF
Pathogenesis of Lipoid Nephrosis: a Disorder of T-cell Function
1974
·
RobertJ. Shalhoub
·
The Lancet
·
1,228
CD8+ T cell differentiation and dysfunction in cancer
2021
·
Mary Philip
, Andrea Schietinger
·
Nature reviews. Immunology
·
1,189
TOX is a critical regulator of tumour-specific T cell differentiation
2019
·
Andrew C. Scott
, Friederike Dündar
, et al.
·
Nature
·
1,185
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
2021
·
Xingzhe Ma
, Liuling Xiao
, et al.
·
Cell Metabolism
·
1,106
PDF
l-arginine availability regulates T-lymphocyte cell-cycle progression
2006
·
Paulo C. Rodriguez
, David G. Quiceno
, et al.
·
Blood
·
1,007
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
2007
·
Carolina Boni
, Paola Fisicaro
, et al.
·
Journal of Virology
·
1,006
Chromatin states define tumour-specific T cell dysfunction and reprogramming
2017
·
Mary Philip
, Lauren Fairchild
, et al.
·
Nature
·
985
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
2019
·
Francesca Alfei
, Kristiyan Kanev
, et al.
·
Nature
·
975
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
2016
·
Nicole E. Scharping
, Ashley V. Menk
, et al.
·
Immunity
·
972
PDF
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
2019
·
Marina Martinez
, Edmund Kyung Moon
·
Frontiers in Immunology
·
929
PDF
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade
2018
·
Ziming Wang
, Ethan G. Aguilar
, et al.
·
Nature Medicine
·
919
The immunosuppressive tumour network: myeloid‐derived suppressor cells, regulatory T cells and natural killer T cells
2012
·
Dennis Lindau
, Paul Gielen
, et al.
·
Immunology
·
889
Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors
2021
·
Shihao Xu
, Omkar Chaudhary
, et al.
·
Immunity
·
878
PDF
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
2020
·
Shogo Kumagai
, Yosuke Togashi
, et al.
·
Nature Immunology
·
866
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
2008
·
R. Brad Jones
, Lishomwa C. Ndhlovu
, et al.
·
The Journal of Experimental Medicine
·
851
PDF
TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients
2015
·
Joe-Marc Chauvin
, Ornella Pagliano
, et al.
·
Journal of Clinical Investigation
·
839
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
2013
·
Jaikumar Duraiswamy
, Karen M. Kaluza
, et al.
·
Cancer Research
·
783
Show more works
View as search
Works count:
5,083
Citation count:
169,700
Year
Topic
Type